Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zecuity PK and Safety in Adolescents with Acute Migraine
NCT02684409Phase 1Completed
- Sponsor
- NuPathe Inc.
- Start
- Aug 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules, Device-based Delivery
01
Overview
Phase 1, open-label, single-arm trial of Zecuity in migraine, sponsored by NuPathe Inc. Primary endpoints: Percentage of Participants with Adverse Events at 30 days, Patch Adherence Evaluation at 4 hours and 6 more. Started Aug 2013; status: completed.
02
Drugs
Zecuity
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02684409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02684409.